FDA Week Highlights: Philips AI Ultrasound Clears, KMDA Approved, Multiple Deals and Halts
Philips (PHG) secured FDA 510(k) clearance for its AI‑enhanced Elevate Plus ultrasound platform, while biotech firm KMDA also received an FDA nod. The week saw Fulcrum Therapeutics (FULC) pause a pivotal study, RMD close a Noctrix acquisition, and Novartis (NVS) make progress in IgA nephropathy, underscining a hectic regulatory cycle.
Wearable Ultrasound Patch Detects Life‑Threatening Complications in High‑Risk Pregnancies
Stanford Medicine scientists introduced the UPatch, a hand‑sized wearable ultrasound patch that continuously tracks fetal‑placental blood flow. In a proof‑of‑concept study of 52 high‑risk pregnancies, the device flagged a severe intrauterine growth restriction case, leading to a timely C‑section and...
Omnipod 6 Improves Time in Range Compared with Omnipod 5
Insulet’s next‑generation Omnipod 6 automated insulin delivery system demonstrated non‑inferiority to the current Omnipod 5 across four primary safety and efficacy endpoints in the STRIVE crossover trial. Adults using Omnipod 6 achieved a higher time‑in‑range (73% vs 70%) and required fewer user‑initiated boluses,...
Hair-Size Microrobots Combine Three Cancer-Fighting Functions in Preclinical Animal Tests
Michigan State University researchers have created a hair‑size 3D‑printed microrobot, TriMag, that integrates magnetic navigation, real‑time imaging, and hyperthermia heating to destroy tumors. In preclinical animal tests, the biodegradable device could be steered through tissue, tracked with magnetic particle imaging,...
WellSpan Health and Philips Seal 7‑Year Alliance to Deploy AI‑Driven Imaging Across 12 Hospitals
WellSpan Health and Dutch health‑tech giant Philips announced a seven‑year strategic alliance covering all 12 WellSpan hospitals, imaging centers and ambulatory surgery sites. The deal makes Philips the preferred vendor for CT, MRI, digital X‑ray, ultrasound and image‑guided therapy, and...
AI‑Enabled Personal Emergency Response Systems Market Forecast to Reach $11.5 B by 2035
Future Market Insights projects the global Personal Emergency Response System (PERS) market to climb from $6.2 B in 2025 to $11.5 B by 2035, a 6.3% CAGR. Growth is anchored by AI‑driven fall detection, mobile wearables and expanding home‑healthcare adoption, especially in...
DNlite™ Biomarker Predicts Renal Risk Independent of Albuminuria in Landmark CREDENCE Trial
Bio Preventive Medicine Corp. and Precision Diabetes unveiled a late‑breaking ADA abstract showing their DNlite™ assay independently forecasts adverse renal outcomes in type‑2 diabetes patients, beyond albuminuria and eGFR, using data from 2,429 CREDENCE participants. The finding could reshape diabetic...
AI Doctor Patch Turns Skin Into Instant Medical Processor
‘A personal, instantaneous doctor integrated into their devices' — how a new skin computer patch could run life-saving AI processes directly on your body https://t.co/BwB7Goj4oo
PET Imaging Links Brain Metabolism Patterns to Effectiveness of Alzheimer's Disease Treatment
A retrospective analysis of 124 patients showed that ¹⁸F‑FDG PET brain‑metabolism patterns can forecast response to FDA‑approved anti‑amyloid drugs. Patients whose scans displayed an Alzheimer’s‑consistent metabolic signature improved cognitive scores, while those with alternative patterns declined. The findings, presented as...
Oxford AI-Designed Vaccine Enters First Human Trials for Crimean-Congo Hemorrhagic Fever
Researchers at the University of Oxford, in partnership with Basecamp Research, have begun the first human clinical trial of a vaccine designed entirely with artificial intelligence. Targeting Crimean-Congo hemorrhagic fever, the trial aims to prove safety and immune response, showcasing...
Medicare’s TAVR Policy Fuels Rural‑Urban Gap, HHS Secretary Warns
At a Cleveland roundtable, HHS Secretary Kennedy warned that Medicare’s coverage‑with‑evidence‑development (CED) requirements for transcatheter aortic valve replacement (TAVR) create a financial barrier for rural hospitals. The policy, driven by the Society for Thoracic Surgeons and the American College of...
The Paradigm Shift in Metabolic Health: Dexcom’s Strategic Acquisition of Nutrisense and the Convergence of Biosensing, AI and Coaching
Dexcom announced the acquisition of Nutrisense, a direct‑to‑consumer metabolic‑wellness platform that pairs CGM hardware with dietitian coaching. The deal marks Dexcom’s pivot from pure sensor sales toward a full‑stack ecosystem that includes AI‑driven analytics and behavioural support. Alongside the purchase,...
Matt Kaeberlein's New Longevity Science Podcast / Youtube Channel (May, 2026)
Matt Kaeberlein and Brian Kennedy introduced LinAge, a second‑generation mortality‑risk clock built on standard clinical chemistry panels, positioning it as a reproducible alternative to first‑generation DNA‑methylation clocks. They highlighted the technical instability and lack of clinical actionability of epigenetic clocks,...
Novel Technique Enables Rapid Sequencing of Rare Hantaviruses
A new primer‑based whole‑genome sequencing method for hantaviruses was unveiled at ASM Microbe 2026. The technique captures each genome segment in a single long read and includes a yield‑boost step for low‑viral‑load samples. In lab tests it generated complete genomes...
Tidepool Showcases New Real-World Clinical Data and Landmark Women’s Health Initiative at ADA 2026
Tidepool used the ADA’s 86th Scientific Sessions to unveil three major initiatives. A 24‑week Diabetes Care Management Program in safety‑net clinics lowered HbA1c by 1.59% and boosted Time‑in‑Range 13.4% through CGM data and remote monitoring. The nonprofit also launched a...
Spinal Cord Stimulation Boosts Arm Strength 32% in Chronic Stroke Patients
University of Pittsburgh researchers reported that seven chronic stroke survivors gained an average 32% increase in arm strength after four weeks of epidural spinal cord stimulation, with less than nine hours of movement training and no serious adverse events. The...
MAIA Therapeutics Targets 100 Patients in Phase 3 NSCLC Trial of Ateganosine
MAIA Therapeutics announced that its Phase 3 THIO-104 trial of ateganosine in third‑line non‑small cell lung cancer has dosed 29 patients across 34 sites and will aim for 100 enrollments by year‑end. The FDA granted Fast Track designation, positioning the...
The Key to AI Cardiology Analytics Is Human Action
Modern cardiovascular information systems (CVIS) now embed AI analytics that quickly surface performance gaps and generate detailed dashboards. However, experts warn that AI can only point out problems; it cannot prescribe or execute solutions. Effective improvement requires multidisciplinary teams—physicians, nurses,...
Socially Assistive Robot Improves Mental Wellbeing in LGBTQ+ Youth at Risk of Self‑Harm
A randomized controlled trial found that a socially assistive robot markedly improved mental wellbeing among LGBTQ+ young people at risk of self‑harm. The study highlights a novel, technology‑driven approach to bridge treatment gaps for a population that faces heightened mental‑health...
Roche Launches Bundibugyo Ebola PCR Test in Six Days Amid Outbreak
Roche announced that its TIB MOLBIOL unit produced a research‑use‑only PCR test for the Bundibugyo Ebola virus in just six days after the genome was published. The rapid assay, compatible with LightCycler and cobas platforms, aims to bolster laboratory response to...
Glooko Introduces the First and Only Pump Settings EHR Integration to Bring Insulin Pump Data Directly Into Clinical Workflows
Glooko announced the launch of its Insulin Pump Settings EHR Integration, a device‑agnostic feature that streams critical pump configuration data directly into electronic health record flowsheets. The integration consolidates up to 24 data points—basal rates, carb ratios, sensitivity factors and...
Olympus’ Keith Boettiger on Robotic GI Surgery Push
Olympus, the world’s largest endoscopy system provider, is expanding into robotic gastrointestinal surgery through its Swan Endosurgical platform and a distribution partnership with EndoRobotics. The company aims to democratize complex procedures such as endoscopic submucosal dissection (ESD) by integrating robotics...
Human‑augmented AI Screening Saves $1.3M, Adds 14.7 QALYs
A cost-effectiveness assessment of using AI in disease screening (modeling) "Implementing an annual ‘copilot’ strategy in all ages would save US$1.32 million while gaining 14.73 quality-adjusted life years over a lifetime [per 100,000 people]" "Our findings demonstrate the indispensable role of human...
Mayo Owns the Model, Microsoft Owns the Pipes: What the Mayo Clinic and Microsoft Frontier Healthcare AI Deal Reveals
On June 2 2026 Mayo Clinic and Microsoft announced a strategic partnership to build a frontier AI model for healthcare. Mayo will own the model and its intellectual property, while Microsoft will deliver it through Azure AI Foundry APIs. The model draws...
Quoin Secures Japan Orphan Drug Designation for QRX003 Targeting Netherton Syndrome
Quoin Pharmaceuticals announced that Japan's Ministry of Health, Labour and Welfare granted orphan drug designation to its QRX003 therapy for Netherton syndrome, promising up to a decade of market exclusivity. The move adds to QRX003’s U.S. pediatric rare‑disease and fast‑track...
GE HealthCare Secures FDA Clearance for AI Radiation Therapy Planning Software
GE HealthCare announced FDA 510(k) clearance for its AI‑enabled auto‑contouring software MIM Contour ProtégéAI+ 2.0. The clearance paves the way for faster radiation‑therapy planning for the roughly 2 million U.S. patients treated each year, and introduces a Predetermined Change Control Plan to...
GH Therapeutics Hits Primary Endpoint in Phase 2a Postpartum Depression Trial
GH Research PLC announced that its inhaled candidate GH001 met the primary endpoint in a Phase 2a trial for postpartum depression, delivering a mean 35.4‑point reduction on the MADRS scale and 100% remission within two hours among ten patients. The...
Before You Buy the Model: A Healthcare AI Readiness Framework for IT Leaders
Healthcare AI demos often look impressive, but many pilots stall when deployed at scale because the underlying infrastructure is weak. The article argues that the real bottleneck is not the model but fragmented data, poor integration, and lack of governance....
FDA Approves GE HealthCare’s MIM Contour ProtégéAI+ 2.0 Software
GE HealthCare secured FDA 510(k) clearance for its AI‑driven MIM Contour ProtégéAI+ 2.0 auto‑contouring software, aimed at speeding radiation therapy planning. The tool automatically delineates anatomical structures on CT and MRI scans, matching or exceeding manual methods. A predetermined change control plan...
Soonr Health Launches Connected at Home Fertility Tracking for Couples in the US
Vespexx Inc. has launched Soonr Health in the United States, a preconception platform that lets both partners track fertility data together. The service integrates the Surearly SMART at‑home hormone testing device, automatically feeding ovulation and hormone results into the app....
Samsung Adds AI‑Powered Health Insights to Upcoming Galaxy Watch
Samsung Electronics announced AI‑enhanced health features for its forthcoming Galaxy Watch, rolling out through a Samsung Health app update on June 8. The new suite translates biometric data into actionable insights, signaling Samsung’s push toward more clinical‑grade consumer wearables.
'World-First' Vaccine Designed by Artificial Intelligence
Researchers at the University of Cambridge have engineered the first vaccine antigen designed entirely by artificial intelligence and tested it in a human safety trial. The AI‑generated "super‑antigen" aims to protect against all known coronaviruses, including current COVID‑19 variants and...
Classiq and Pontificia Universidad Católica De Chile Launch Latin America’s First Quantum Machine Learning Consortium for Computational Pathology
Classiq and Pontificia Universidad Católica de Chile have announced the launch of Latin America’s first Quantum Machine Learning Consortium dedicated to computational pathology. The 12‑month initiative will target renal pathology, developing quantum‑enhanced models for kidney lesion classification and glomerular segmentation....
AI Model Enables More than a Million-Fold Acceleration of Diffuse Optical Tomography for Real-Time Diagnosis
Researchers at the University of Tsukuba unveiled an AI‑driven model that predicts light propagation for diffuse optical tomography in about 2 ms, delivering a speedup of more than one million times over traditional simulations. The neural‑network emulator, trained on extensive Monte‑Carlo...
CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery
CereVasc announced an $85 million Series C round, bringing its total capital raised since 2014 to over $200 million. The funding, led by Piper Sandler Merchant Banking with participation from Medtronic, Johnson & Johnson Innovation, Bain Capital and Perceptive Xontogeny, will finance the pivotal trial...
Alnylam Inks $2 B AI Drug Development Pact with Inceptive Ink
Alnylam Pharmaceuticals has signed a partnership with AI‑driven biotech Inceptive Ink valued at up to $2 billion, delivering a $30 million upfront payment. The deal merges Alnylam’s RNAi expertise with Inceptive’s foundation‑model AI to accelerate nucleic‑acid drug design under Alnylam’s 2030 strategy.
5 Diabetes Tech Gadgets Showing How AI Is Changing Glucose Monitoring
AI is reshaping diabetes care as a new wave of glucose sensors, wearables, and automated insulin pumps moves from passive tracking to predictive, real‑time decision support. Dexcom’s Stelo became the first over‑the‑counter CGM in 2024, while Abbott’s Lingo entered Walmart...
Risk Stratification of Postoperative Enteral Feeding Intolerance Using Explainable Machine Learning in Oral Cancer Free Flap Reconstruction
A retrospective study of 752 oral‑cancer patients undergoing free‑flap reconstruction developed an interpretable machine‑learning model to predict postoperative enteral feeding intolerance (FI). Using LASSO, nine peri‑operative variables—including fasting glucose, serum potassium, tumor stage, operative time and the Advanced Lung Cancer...
Machine Learning Based on Body Composition Radiomics for Predicting Early Recurrence in Colorectal Cancer: A Multicenter Study
A multicenter retrospective study of 917 colorectal cancer patients created an interpretable machine‑learning model that predicts early recurrence using pre‑operative CT body‑composition radiomics. After extracting 1,896 features from skeletal muscle, subcutaneous, intermuscular and visceral fat at the L3 level, an...
Radiologists: Take the Deep Dive Into Advanced Cardiovascular CT at SCCT
The Society of Cardiovascular Computed Tomography (SCCT) is positioning itself as the premier forum for both radiologists and cardiologists as cardiovascular CT matures. It helped secure a Category I CPT code for coronary CTA in 2010 and a Class I guideline endorsement...
Plaque Imaging, AI and Structural Heart Disease in the Spotlight at SCCT 2026 Meeting
The SCCT 2026 meeting spotlighted advances in coronary CT angiography, including AI‑driven plaque characterization aimed at primary prevention of heart attacks. Sessions highlighted CT‑derived fractional flow reserve (CT‑FFR) as a non‑invasive functional tool and photon‑counting CT for higher resolution with...
Philips and WellSpan Health Seal 7‑Year Alliance to Deploy AI‑Driven Imaging Across 12 Hospitals
Royal Philips and WellSpan Health announced a seven‑year strategic alliance that makes Philips the preferred vendor for imaging across all 12 WellSpan hospitals, diagnostic centers and ambulatory surgery sites. The partnership includes joint R&D, AI‑enabled workflow tools and a coordinated...
How Agentic AI Can Bolster Patient Access Centers
Innovaccer’s new survey of 110 health‑system executives reveals that a typical 400‑bed hospital loses about $6.2 million each year due to avoidable referral leakage and scheduling failures. Referral conversion rates vary dramatically, with top performers turning 76 % of referrals into appointments...
Smart Toilets Could Detect Colorectal Cancer Early
"My toilet saved my life." That is the sentence Throne Sciences CEO Scott Hickle wants Americans to be able to say a decade from now. The idea: a smart toilet that quietly screens you every day for early signs of colorectal and...
Gene Editing Could Deliver One‑Shot Heart Disease Cure
Gene editing may mean a one-time treatment for heart disease will be available soon. Seems more important than a lot of other news but not getting a lot of attention.
Philips and WellSpan Health Launch 7-Year Strategic AI and Imaging Partnership
Philips and WellSpan Health have signed a seven‑year strategic alliance covering all 12 hospitals, diagnostic centers, and ambulatory surgery sites in Central Pennsylvania and Northern Maryland. The deal makes Philips the preferred vendor for CT, MR, digital X‑ray, ultrasound and...
Glass Boosts Speed and Handles More Patient Context
Several fantastic updates to Glass in the last week or so. Improved speed of response and the ability to ingest more patient context are my favorites.
Medtronic Seeks Clearance for Hugo Surgical Robot in More Indications
Medtronic announced it has submitted 510(k) applications to expand its Hugo surgical robot into general and gynecologic procedures, adding to the urology clearance it received last year. The new indications would cover the majority of surgeries currently performed with Intuitive’s...
Vida Health Partners with Instacart to Launch Category-Specific Grocery Stipends for Cardiometabolic Care
Vida Health has sealed a nationwide partnership with Instacart to embed category‑specific grocery stipends into its virtual cardiometabolic care model. The program uses Instacart Health Fresh Funds to give members direct financial credits for dietitian‑approved foods, targeting social determinants of...
Black and Latina Women Face 20‑30% Higher Misdiagnosis Rate, Driving Bigger Bills
A recent study finds Black and Latina women in the United States are 20‑30% more likely to receive a misdiagnosis than white women, a disparity that translates into significantly larger medical bills. Advocates say the pattern reflects deep‑seated inequities in...